{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:35:07Z","timestamp":1794407707390,"version":"4.9.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cld.2024.06.008","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T13:27:59Z","timestamp":1721827679000},"page":"663-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Gut Bacteria in Alcohol-Associated Liver Disease"],"prefix":"10.1016","volume":"28","author":[{"given":"Yongqiang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schnabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2024.06.008_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Collaborators","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.008_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2021.7683","article-title":"Diagnosis and treatment of alcohol-associated liver disease: a review","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.cld.2024.06.008_bib3","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1016\/S2468-2667(20)30062-1","article-title":"Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study","volume":"5","author":"Julien","year":"2020","journal-title":"Lancet Public Health"},{"issue":"42","key":"10.1016\/j.cld.2024.06.008_bib4","doi-asserted-by":"crossref","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","article-title":"Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity","volume":"111","author":"Leclercq","year":"2014","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"8","key":"10.1016\/j.cld.2024.06.008_bib5","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/jgh.16199","article-title":"Alcohol, the gut microbiome, and liver disease","volume":"38","author":"Jew","year":"2023","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2024.06.008_bib6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"10.1016\/j.cld.2024.06.008_bib7","doi-asserted-by":"crossref","first-page":"100909","DOI":"10.1016\/j.jhepr.2023.100909","article-title":"Phage therapy: targeting intestinal bacterial microbiota for the treatment of liver diseases","volume":"5","author":"Fujiki","year":"2023","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib8","doi-asserted-by":"crossref","first-page":"2211922","DOI":"10.1080\/19490976.2023.2211922","article-title":"The emerging role of the gut mycobiome in liver diseases","volume":"15","author":"Szostak","year":"2023","journal-title":"Gut Microb"},{"issue":"4","key":"10.1016\/j.cld.2024.06.008_bib9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jhep.2022.12.006","article-title":"Fungal infections and the fungal microbiome in hepatobiliary disorders","volume":"78","author":"Hartmann","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2024.06.008_bib10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1365-2036.2007.03302.x","article-title":"Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features","volume":"25","author":"Mathurin","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"26","key":"10.1016\/j.cld.2024.06.008_bib11","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMra2207599","article-title":"Alcohol-associated hepatitis","volume":"387","author":"Bataller","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2024.06.008_bib12","doi-asserted-by":"crossref","first-page":"e201997","DOI":"10.1001\/jamanetworkopen.2020.1997","article-title":"Trends in the burden of chronic liver disease among hospitalized US adults","volume":"3","author":"Hirode","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.cld.2024.06.008_bib13","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s10620-020-06263-w","article-title":"Hospitalizations for acute on chronic liver failure at Academic compared to non-academic centers have higher mortality","volume":"66","author":"Singal","year":"2021","journal-title":"Digest Dis Sci"},{"issue":"4","key":"10.1016\/j.cld.2024.06.008_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/apt.16461","article-title":"Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics","volume":"54","author":"Singal","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2024.06.008_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2020.07.007","article-title":"Microbiota and fatty liver disease-the known, the unknown, and the future","volume":"28","author":"Lang","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.cld.2024.06.008_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41575-023-00771-6","article-title":"Gut-liver axis: barriers and functional circuits","volume":"20","author":"Pabst","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2024.06.008_bib17","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","article-title":"The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease","volume":"20","author":"Diaz","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s40168-017-0359-2","article-title":"Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease","volume":"5","author":"Dubinkina","year":"2017","journal-title":"Microbiome"},{"issue":"5","key":"10.1016\/j.cld.2024.06.008_bib19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2024.06.008_bib20","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3390\/ijms24032461","article-title":"Microbiome alterations in alcohol use disorder and alcoholic liver disease","volume":"24","author":"Litwinowicz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cld.2024.06.008_bib21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","article-title":"Recent advances in understanding of pathogenesis of alcohol-associated liver disease","volume":"18","author":"Wu","year":"2023","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.008_bib22","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"issue":"7516","key":"10.1016\/j.cld.2024.06.008_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cld.2024.06.008_bib24","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.008_bib25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30832","article-title":"Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis","volume":"71","author":"Lang","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2024.06.008_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jhep.2019.09.029","article-title":"The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease","volume":"72","author":"Chu","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.06.008_bib27","doi-asserted-by":"crossref","first-page":"699253","DOI":"10.3389\/fphys.2021.699253","article-title":"Dynamic changes of the fungal microbiome in alcohol use disorder","volume":"12","author":"Hartmann","year":"2021","journal-title":"Front Physiol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.008_bib28","doi-asserted-by":"crossref","first-page":"100220","DOI":"10.1016\/j.jhepr.2020.100220","article-title":"Gut dysbiosis as a driver in alcohol-induced liver injury","volume":"3","author":"Fairfield","year":"2021","journal-title":"JHEP Rep"},{"issue":"7","key":"10.1016\/j.cld.2024.06.008_bib29","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI90562","article-title":"Intestinal fungi contribute to development of alcoholic liver disease","volume":"127","author":"Yang","year":"2017","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib30","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1038\/s41467-021-27385-3","article-title":"CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease","volume":"12","author":"Duan","year":"2021","journal-title":"Nat Commun"},{"issue":"7919","key":"10.1016\/j.cld.2024.06.008_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-022-04949-x","article-title":"Within-host evolution of a gut pathobiont facilitates liver translocation","volume":"607","author":"Yang","year":"2022","journal-title":"Nature"},{"issue":"7840","key":"10.1016\/j.cld.2024.06.008_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-020-2977-2","article-title":"Commensal-driven immune zonation of the liver promotes host defence","volume":"589","author":"Gola","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/hep.24018","article-title":"Enteric dysbiosis associated with a mouse model of alcoholic liver disease","volume":"53","author":"Yan","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2024.06.008_bib34","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.gastro.2014.09.014","article-title":"Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice","volume":"148","author":"Chen","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cld.2024.06.008_bib36","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s10620-023-07860-1","article-title":"Differences in bacterial translocation and liver injury in ethanol versus diet-induced liver disease","volume":"68","author":"Hsu","year":"2023","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.cld.2024.06.008_bib37","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.chom.2022.05.002","article-title":"Host hepatic metabolism is modulated by gut microbiota-derived sphingolipids","volume":"30","author":"Le","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"10","key":"10.1016\/j.cld.2024.06.008_bib38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","article-title":"Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms","volume":"19","author":"Cani","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"33","key":"10.1016\/j.cld.2024.06.008_bib39","doi-asserted-by":"crossref","first-page":"12359","DOI":"10.1074\/jbc.RA119.007409","article-title":"Murine macrophage autophagy protects against alcohol-induced liver injury by degrading interferon regulatory factor 1 (IRF1) and removing damaged mitochondria","volume":"294","author":"Liang","year":"2019","journal-title":"J\u00a0Biol Chem"},{"issue":"10","key":"10.1016\/j.cld.2024.06.008_bib40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.tim.2020.04.011","article-title":"Label or concept - what is a pathobiont?","volume":"28","author":"Jochum","year":"2020","journal-title":"Trends Microbiol"},{"issue":"6867","key":"10.1016\/j.cld.2024.06.008_bib41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/415084a","article-title":"Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction","volume":"415","author":"Haas","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41467-017-00796-x","article-title":"Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus","volume":"8","author":"Llorente","year":"2017","journal-title":"Nat Commun"},{"issue":"7783","key":"10.1016\/j.cld.2024.06.008_bib43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cld.2024.06.008_bib44","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.hbpd.2023.05.003","article-title":"Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure","volume":"22","author":"Hartmann","year":"2023","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"4","key":"10.1016\/j.cld.2024.06.008_bib45","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/liv.14377","article-title":"Cytolysin-positive Enterococcus faecalis is not increased in patients with non-alcoholic steatohepatitis","volume":"40","author":"Lang","year":"2020","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/HEP.0000000000000324","article-title":"IgY antibodies against cytolysin reduce ethanol-induced liver disease in mice","volume":"78","author":"Cabre","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2024.06.008_bib47","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.chom.2023.02.001","article-title":"Candida albicans-specific Th17 cell-mediated response contributes to alcohol-associated liver disease","volume":"31","author":"Zeng","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.cld.2024.06.008_bib48","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/cmi.2014.110","article-title":"Over-activation of TLR5 signaling by high-dose flagellin induces liver injury in mice","volume":"12","author":"Xiao","year":"2015","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"10.1016\/j.cld.2024.06.008_bib49","first-page":"616","article-title":"Targeting the gut microbiota to treat alcoholic liver diseases : evidence and promises","volume":"83","author":"Leclercq","year":"2020","journal-title":"Acta Gastro-Enterol Belg"},{"issue":"5","key":"10.1016\/j.cld.2024.06.008_bib50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41579-023-00998-9","article-title":"Utilization of the microbiome in personalized medicine","volume":"22","author":"Ratiner","year":"2024","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3390\/ijms23010426","article-title":"Role of microbiota-derived metabolites in alcoholic and non-alcoholic fatty liver diseases","volume":"23","author":"Park","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cld.2024.06.008_bib52","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2016.04.032","article-title":"Microbiome therapeutics - advances and challenges","volume":"105","author":"Mimee","year":"2016","journal-title":"Adv Drug Deliver Rev"},{"issue":"2","key":"10.1016\/j.cld.2024.06.008_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.alcohol.2008.12.009","article-title":"Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis","volume":"43","author":"Forsyth","year":"2009","journal-title":"Alcohol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hep.31178","article-title":"Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity","volume":"72","author":"Smirnova","year":"2020","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2024.06.008_bib55","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/liv.14106","article-title":"Faecal microbiota from patients with cirrhosis has a low capacity to ferment non-digestible carbohydrates into short-chain fatty acids","volume":"39","author":"Jin","year":"2019","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.cld.2024.06.008_bib56","doi-asserted-by":"crossref","first-page":"11595","DOI":"10.1096\/fj.201901327R","article-title":"Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis","volume":"33","author":"Juanola","year":"2019","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.cld.2024.06.008_bib57","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.4983","article-title":"Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation","volume":"243","author":"Sheng","year":"2017","journal-title":"J\u00a0Pathol"},{"issue":"9","key":"10.1016\/j.cld.2024.06.008_bib58","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/jgh.13731","article-title":"Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury","volume":"32","author":"Cresci","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/nu11010097","article-title":"A\u00a0designer synbiotic attenuates chronic-binge ethanol-induced gut-liver injury in mice","volume":"11","author":"Roychowdhury","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib60","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020868118","article-title":"Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22","volume":"118","author":"Wang","year":"2021","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"8","key":"10.1016\/j.cld.2024.06.008_bib61","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gutjnl-2018-317232","article-title":"Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice","volume":"68","author":"Hendrikx","year":"2019","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cld.2024.06.008_bib62","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/acer.15048","article-title":"Engineered bacteria producing aryl-hydrocarbon receptor agonists protect against ethanol-induced liver disease in mice","volume":"47","author":"Kouno","year":"2023","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2024.06.008_bib63","doi-asserted-by":"crossref","first-page":"1212742","DOI":"10.3389\/fphar.2023.1212742","article-title":"Harnessing the potential of probiotics in the treatment of alcoholic liver disorders","volume":"14","author":"Mishra","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cld.2024.06.008_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9097276","article-title":"Probiotics for alleviating alcoholic liver injury","volume":"2019","author":"Gu","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.cld.2024.06.008_bib65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1471-230X-13-151","article-title":"The protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injury","volume":"13","author":"Chang","year":"2013","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12602-022-10005-x","article-title":"Compound probiotic ameliorates acute alcoholic liver disease in mice by modulating gut microbiota and maintaining intestinal barrier","volume":"15","author":"Liu","year":"2023","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chom.2019.11.001","article-title":"Roseburia spp. abundance associates with alcohol consumption in humans and its administration ameliorates alcoholic fatty liver in mice","volume":"27","author":"Seo","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.cld.2024.06.008_bib68","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2281014","article-title":"Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease","volume":"15","author":"Eom","year":"2023","journal-title":"Gut Microb"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib69","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/1040841X.2022.2037506","article-title":"Akkermansia muciniphila plays critical roles in host health","volume":"49","author":"Zhao","year":"2023","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib70","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1851986","article-title":"The role of gut vascular barrier in experimental alcoholic liver disease and A.\u00a0muciniphila supplementation","volume":"12","author":"Grander","year":"2020","journal-title":"Gut Microb"},{"issue":"22","key":"10.1016\/j.cld.2024.06.008_bib71","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"10","key":"10.1016\/j.cld.2024.06.008_bib72","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/metabo13101057","article-title":"Akkermansia muciniphila ameliorates alcoholic liver disease in experimental mice by regulating serum metabolism and improving gut dysbiosis","volume":"13","author":"Fang","year":"2023","journal-title":"Metabolites"},{"issue":"11","key":"10.1016\/j.cld.2024.06.008_bib73","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/MEG.0000000000000458","article-title":"Effects of probiotics (cultured Lactobacillus subtilis\/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study","volume":"27","author":"Han","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2024.06.008_bib74","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.14309\/ajg.0000000000002283","article-title":"The beneficial effects of Lactobacillus GG therapy on liver and drinking assessments in patients with moderate alcohol-associated hepatitis","volume":"118","author":"Vatsalya","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.cld.2024.06.008_bib75","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/s41430-020-00852-8","article-title":"Effect of Lactobacillus casei on lipid metabolism and intestinal microflora in patients with alcoholic liver injury","volume":"75","author":"Li","year":"2021","journal-title":"Eur J Clin Nutr"},{"issue":"4","key":"10.1016\/j.cld.2024.06.008_bib76","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","article-title":"Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae","volume":"30","author":"Yuan","year":"2019","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib77","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1038\/s41467-023-39028-w","article-title":"Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae","volume":"14","author":"Gan","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib78","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/s41467-023-39029-9","article-title":"Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis","volume":"14","author":"Ichikawa","year":"2023","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.cld.2024.06.008_bib79","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jceh.2022.01.001","article-title":"Long-term outcomes of stool transplant in alcohol-associated hepatitis-analysis of clinical outcomes, relapse, gut microbiota and comparisons with standard care","volume":"12","author":"Philips","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2024.06.008_bib80","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12664-018-0859-4","article-title":"Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis","volume":"37","author":"Philips","year":"2018","journal-title":"Indian J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2024.06.008_bib81","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12072-022-10312-z","article-title":"Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial","volume":"16","author":"Sharma","year":"2022","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.cld.2024.06.008_bib82","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib83","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12072-022-10438-0","article-title":"Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial","volume":"17","author":"Pande","year":"2023","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.cld.2024.06.008_bib84","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2024.06.008_bib85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apt.16148","article-title":"Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020","volume":"53","author":"Marcella","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.cld.2024.06.008_bib86","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/hep.31496","article-title":"A\u00a0randomized clinical trial of fecal microbiota transplant for alcohol use disorder","volume":"73","author":"Bajaj","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2024.06.008_bib87","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2018.10.004","article-title":"Only in the darkness can you see the stars: severe alcoholic hepatitis and higher grades of acute-on-chronic liver failure","volume":"70","author":"Philips","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2024.06.008_bib88","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s13668-020-00313-5","article-title":"Probiotics and the microbiota-gut-brain Axis: focus on psychiatry","volume":"9","author":"Morkl","year":"2020","journal-title":"Curr Nutr Rep"},{"issue":"20","key":"10.1016\/j.cld.2024.06.008_bib89","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1007\/s00018-017-2550-9","article-title":"Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis","volume":"74","author":"Westfall","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.cld.2024.06.008_bib90","article-title":"Gut microbiome-brain-cirrhosis axis","author":"Smith","year":"2023","journal-title":"Hepatology"},{"issue":"40","key":"10.1016\/j.cld.2024.06.008_bib91","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.3748\/wjg.v26.i40.6141","article-title":"Role of gut microbiota via the gut-liver-brain axis in digestive diseases","volume":"26","author":"Ding","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2024.06.008_bib92","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/apt.12695","article-title":"Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis","volume":"39","author":"Bajaj","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cld.2024.06.008_bib93","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1053\/j.gastro.2014.08.031","article-title":"Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial","volume":"147","author":"Dhiman","year":"2014","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2024.06.008_bib94","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:42:09Z","timestamp":1728520929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326124000564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1089326124000564"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2024.06.008","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut Bacteria in Alcohol-Associated Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2024.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}